ArticleSkin health and disease2025

Response to pembrolizumab in a patient with xeroderma pigmentosum, metastatic cutaneous melanoma and multiple squamous cell carcinomas: a case report.

Júlia C Martins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.